FT Vest Gold Strategy Target Income ETF (BATS: IGLD)

FT Vest Gold Strategy Target Income ETF (BATS:IGLD), Quote.Headers.trade-ideas

Internet Gold-Golden

The Fund seeks to deliver participation in the price returns of the SPDR Gold Trust (the Underlying ETF) while providing a consistent level of income through a portfolio substantially composed of short-term U.S. Treasury securities, cash and cash equivalents, and in the shares of a wholly-owned subsidiary (the Subsidiary) that holds FLexible Exchange Options (FLEX Options) that reference the price performance of the Underlying ETF. The Funds investment sub-advisor is Vest Financial LLC (Vest or the Sub-Advisor). As discussed in greater detail below, the Fund will not fully participate in gains experienced by the Underlying ETF.

Dreyfus Government Cash Management

FT Cboe Vest Gold Strategy Target Income ETF

News

Movers & Shakers

Pre-Market Outlook

Markets

Movers

Trading Ideas

General

ABEO

AKBA

ALBO

ALIM

APTX

ARAV

AXLA

BBAR

BXRX

CENT

CLVS

CORV

CPST

DAKT

DPLO

DTIL

ELOX

ENOB

ETNB

EYEN

HARP

HEPA

IFRX

IGLD

IMGN

MANU

MCRB

MRKR

MYOV

NTWK

OBSV

OCGN

OCUL

ONTX

ORMP

OVID

PPDF

PTGX

QFIN

SBPH

SFET

TNXP

TTGT

VRCA

52 Biggest Movers From Wednesday

AAOI

ADNT

AIRG

APDN

AQST

ASLN

ASMB

CABA

CARB

CLMT

CNST

CNTG

CTMX

DWSN

FGEN

FOMX

INMD

INWK

JNCE

KRKR

LEAF

LPCN

MNLO

MYOK

NEPT

NINE

NXTC

PACD

PCTI

PNRL

PRTS

PRVL

QRTEA

RAPT

SGMS

SMLP

SWCH

TMST

TRNX

TRXC

UXIN

XPEL

58 Biggest Movers From Yesterday

Intraday Update

GRVY

SPWR

VNCE

38 Stocks Moving In Monday&#39;s Mid-Day Session

FT Vest Gold Strategy Target Income ETF

INTERNET GOLD GLDEN LINES by Internet Gold-Golden Lines Ltd.

Internet Gold-Golden Lines Ltd

Internet Gold - Golden Lines Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/igld#NASDAQ">IGLD</a>)
Due to extraordinary trade in the Company's shares, the Company wishes to reiterate the information announced in the Company's public announcement that following the closing of the Searchlight Transaction, which is scheduled to occur on December 02, 2019, the Company will not be able to fully pay its debts and it intends to initiate a creditors' arrangement which will be submitted to the applicable Israeli court pursuant to Section 350 of the Israeli Companies Law. The Company anticipates that pursuant to such arrangement, the existing shares of the Company will be nullified and that at the same time, the creditors of the Company and the party or parties to the new Transaction to be voted by the debenture holders (if completed) will receive, among other consideration, 100% of the outstanding shares of the Company.
As also disclosed, the offer that will be voted on will be included in the Company's creditors' arrangement and will be subject to the approval of the applicable Israeli court

Internet Gold Reiterates the Information Announced in the Company's Public Announcement That Following the Closing of the Searchlight Transaction

<h3>Gainers</h3>
<ul>
<li>AVX Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/avx#NYSE">AVX</a>) shares climbed 36.4% to close at $20.51 on Wednesday after Kyocera announced a proposal to acquire all shares of the company it does not own for $19.50 per share.</li>
<li>Hepion Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hepa#NASDAQ">HEPA</a>) gained 35.7% to close at $6.27 after climbing 28.69% on Tuesday.</li>
<li>Onconova Therapeutics Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ontx#NASDAQ">ONTX</a>) shares gained 33.9% to close at $0.1593.</li>
<li>GTT Communications, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gtt#NYSE">GTT</a>) rose 25.7% to close at $8.57.</li>
<li>Ovid Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ovid#NASDAQ">OVID</a>) gained 19.2% to close at $3.72.</li>
<li>Internet Gold - Golden Lines Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/igld#NASDAQ">IGLD</a>) climbed 20.1% to close at $14.60.</li>
<li>360 Finance, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qfin#NASDAQ">QFIN</a>) rose 16.7% to close at $9.15 following Q3 results.</li>
<li>Abeona Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/abeo#NASDAQ">ABEO</a>) rose 16.2% to close at $3.40.</li>
<li>Ocugen Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocgn#NASDAQ">OCGN</a>) gained 15.9% to close at $0.3580 after Chardan Capital initiated coverage on the company&#39;s stock with a Buy rating and a $2 price target. The company also reported insider buying of 200K shares.</li>
<li>Oramed Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ormp#NASDAQ">ORMP</a>) rose 15.8% to close at $3.74.</li>
<li>Myovant Sciences Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/myov#NYSE">MYOV</a>) gained 14.8% to close at $17.24.</li>
<li>ObsEva SA (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/obsv#NASDAQ">OBSV</a>) rose 13.9% to close at $4.19.</li>
<li>Spring Bank Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sbph#NASDAQ">SBPH</a>) climbed 13.9% to close at $3.70.</li>
<li>Clovis Oncology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clvs#NASDAQ">CLVS</a>) surged 13.6% to close at $12.41.</li>
<li>InflaRx N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ifrx#NASDAQ">IFRX</a>) gained 12.7% to close at $3.47.</li>
<li>Alimera Sciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alim#NASDAQ">ALIM</a>) climbed 12.7% to close at $5.61.</li>
<li>Precision BioSciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dtil#NASDAQ">DTIL</a>) rose 12.5% to close at $18.18</li>
<li>Diplomat Pharmacy, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dplo#NYSE">DPLO</a>) climbed 12.2% to close at $4.90 on continued upward momentum. The stock dropped roughly 58% following mixed Q3 earnings. It is still trading within that gap.</li>
<li>Eyenovia, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eyen#NASDAQ">EYEN</a>) rose 12% to close at $4.10.</li>
<li>Ocular Therapeutix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocul#NASDAQ">OCUL</a>) surged 12% to close at $3.55.</li>
<li>Albireo Pharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/albo#NASDAQ">ALBO</a>) gained 11.7% to close at $22.04.</li>
<li>Banco BBVA Argentina S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bbar#NYSE">BBAR</a>) rose 11.7% to close at $4.00.</li>
<li>Akebia Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/akba#NASDAQ">AKBA</a>) shares surged 11.7% to close at $5.55</li>
<li>Ossen Innovation Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/osn#NASDAQ">OSN</a>) gained 11.5% to close at $3.30.</li>
<li>Protagonist Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ptgx#NASDAQ">PTGX</a>) climbed 11.5% to close at $8.70.</li>
<li>Box Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/box#NYSE">BOX</a>) rose 11.5% to close at $18.62 after the company reported better-than-expected Q3 sales results.</li>
<li>Tonix Pharmaceuticals Holding Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tnxp#NASDAQ">TNXP</a>) shares rose 11.4% to close at $1.17 after the company announced it received the official minutes from the Breakthrough Therapy Type B Clinical Guidance meeting with the FDA for Tonmya. The minutes are consistent with guidance received at the meeting.</li>
<li>Manchester United plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/manu#NYSE">MANU</a>) gained 11.2% to close at $18.62.</li>
<li>Eloxx Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/elox#NASDAQ">ELOX</a>) surged 11.2% to close at $5.07.</li>
<li>Harpoon Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/harp#NASDAQ">HARP</a>) gained 11.1% to close at $18.75.</li>
<li>Axcella Health Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/axla#NASDAQ">AXLA</a>) rose 10.9% to close at $3.97.</li>
<li>Aptinyx Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aptx#NASDAQ">APTX</a>) gained 10.8% to close at $3.89.</li>
<li>Sculptor Capital Management, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/scu#NYSE">SCU</a>) surged 10.4% to close at $19.50.</li>
<li>FinVolution Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ppdf#NYSE">PPDF</a>) rose 9.8% to close at $2.70 after gaining 5.13% on Tuesday.</li>
<li>ImmunoGen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imgn#NASDAQ">IMGN</a>) gained 8.9% to close at $3.69.</li>
<li>McDermott International Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mdr#NYSE">MDR</a>) climbed 8.3% to close at $0.8159.</li>
</ul>

<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>
<h3>Losers</h3>
<ul>
<li>Evolent Health, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/evh#NYSE">EVH</a>) shares tumbled 27.3% to close at $7.76 on Wednesday after Passport Health, which is owned by the company, was left out of large Medicaid contracts in Kentucky.</li>
<li>Baudax Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bxrx#NASDAQ">BXRX</a>) dropped 18.4% to close at $5.60.</li>
<li>Central Garden &amp; Pet Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cent#NASDAQ">CENT</a>) fell 17.5% to close at $25.88 after the company reported worse-than-expected Q4 earnings.</li>
<li>Safe-T Group Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sfet#NASDAQ">SFET</a>) fell 12.7% to close at $5.94 after reporting Q3 results.</li>
<li>Aravive, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arav#NASDAQ">ARAV</a>) declined 12.2% to close at $8.25 after the company reported pricing of public offering of common stock at $7.50 per share.</li>
<li>89bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/etnb#NASDAQ">ETNB</a>) shares fell 9.9% to close at $30.12.</li>
<li>Verrica Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vrca#NASDAQ">VRCA</a>) dropped 9.9% to close at $15.71. Verrica Pharmaceuticals announced FDA filing acceptance of New Drug Application for VP-102 for the treatment of molluscum contagiosum.</li>
<li>Correvio Pharma Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/corv#NASDAQ">CORV</a>) fell 9.8% to close at $2.12.</li>
<li>Enochian Biosciences Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/enob#NASDAQ">ENOB</a>) dropped 9.4% to close at $5.96.</li>
<li>Daktronics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dakt#NASDAQ">DAKT</a>) dipped 8.7% to close at $6.28 after the company reported downbeat Q2 results.</li>
<li>Capstone Turbine Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cpst#NASDAQ">CPST</a>) fell 8.6% to close at $3.96.</li>
<li>Marker Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrkr#NASDAQ">MRKR</a>) dropped 8.4% to close at $3.05.</li>
<li>Seres Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mcrb#NASDAQ">MCRB</a>) dipped 8.1% to close at $3.90.</li>
<li>NetSol Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ntwk#NASDAQ">NTWK</a>) shares declined 8% to close at $3.68.</li>
<li>TechTarget, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ttgt#NASDAQ">TTGT</a>) dropped 7.9% to close at $26.53.</li>
<li>Deere &amp; Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/de#NYSE">DE</a>) fell 4.3% to close at $169.06 after the company expected a decline in agricultural and construction sales for FY20.</li>
</ul>

Internet Gold Shares Halted On Circuit Breaker

Internet Gold Says Is Considering Withdrawing Appeal From Nasdaq Listing Qualifications Staff

Internet Gold Says Purchasers In Searchlight Deal Notified Co. Ministry Of Communications Issued Control Permit In Bezeq; Expected Closing Date Dec. 2, 2019

Earnings

Internet Gold Q3 Total Assets $4.836M, Total Liabilities $5.215M

<h3>Gainers</h3>
<ul>
<li>XPEL, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xpel#NASDAQ">XPEL</a>) shares jumped 30.8% to close at $14.14 on Monday after reporting strong Q3 results.</li>
<li>89bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/etnb#NASDAQ">ETNB</a>) gained 30% to close at $20.80. 89bio priced its IPO at $16 per share.</li>
<li>Cabaletta Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/caba#NASDAQ">CABA</a>) rose 25.2% to close at $13.92.</li>
<li>Carbonite, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/carb#NASDAQ">CARB</a>) shares jumped 24.7% to close at $22.95 on Monday after the company announced it would be acquired by OpenText for $23 per share in cash.</li>
<li>Nine Energy Service, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nine#NYSE">NINE</a>) shares gained 21.3% to close at $5.97</li>
<li>Taronis Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trnx#NASDAQ">TRNX</a>) shares climbed 18.8% to close at $2.09 on Monday.</li>
<li>Liquid Media Group Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/yvr#NASDAQ">YVR</a>) rose 18.1% to close at $2.54.</li>
<li>Leaf Group Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/leaf#NYSE">LEAF</a>) gained 17.7% to close at $4.92.</li>
<li>TransEnterix, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/trxc#NYSE">TRXC</a>) shares rose 17.5% to close at $0.2663 after the company announced that Anthony Fernando was appointed as the new President and CEO.</li>
<li>Jounce Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jnce#NASDAQ">JNCE</a>) shares gained 15.8% to close at $4.70.</li>
<li>Entercom Communications Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/etm#NYSE">ETM</a>) gained 13.2% to close at $4.89 on continued momentum after the company reported better-than-expected Q3 EPS and sales results.</li>
<li>InMode Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inmd#NASDAQ">INMD</a>) shares climbed 12.3% to close at $45.41 on continued upward momentum. The stock has increased roughly 210% since its IPO in August 7.</li>
<li>Dawson Geophysical Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dwsn#NASDAQ">DWSN</a>) gained 11.7% to close at $2.78.</li>
<li>Applied Optoelectronics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aaoi#NASDAQ">AAOI</a>) surged 11.7% to close at $12.15.</li>
<li>U.S. Auto Parts Network, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prts#NASDAQ">PRTS</a>) jumped 11.7% to close at $2.49.</li>
<li>Qurate Retail, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qrtea#NASDAQ">QRTEA</a>) rose 11.4% to close at $10.47 after the company reported better-than-expected Q3 EPS results.</li>
<li>Constellation Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnst#NASDAQ">CNST</a>) gained 11.2% to close at $34.38.</li>
<li>The Trade Desk, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ttd#NASDAQ">TTD</a>) rose 11% to close at $217.01 on continued momentum after the company reported better-than-expected Q3 EPS and sales results. The company also had raised its FY19 sales guidance above analyst estimates.</li>
<li>Titan International, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/twi#NYSE">TWI</a>) gained 10.9% to close at $3.06.</li>
<li>Aquestive Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aqst#NASDAQ">AQST</a>) shares jumped 10.8% to close at $5.99.</li>
<li>Calumet Specialty Products Partners, L.P. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clmt#NASDAQ">CLMT</a>) jumped 10.6% to close at $3.76 after the company reported strategic divestiture of San Antonio Refinery, related assets to Starlight for $63 million in cash.</li>
<li>PCTEL, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pcti#NASDAQ">PCTI</a>) shares rose 10.3% to close at $9.03.</li>
<li>Prevail Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prvl#NASDAQ">PRVL</a>) shares surged 10% to close at $13.53.</li>
<li>Switch, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/swch#NYSE">SWCH</a>) gained 10% to close at $15.57. Credit Suisse maintained Switch with an Outperform and raised the price target from $18 to $19.</li>
<li>Genie Energy Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gne#NYSE">GNE</a>) gained 9.7% to close at $7.90.</li>
<li>Medifast, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/med#NYSE">MED</a>) shares gained 8.4% to close at $80.57.</li>
<li>CENTOGENE B.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cntg#NASDAQ">CNTG</a>) shares gained 7.2% to close at $13.92.</li>
<li>Walgreens Boots Alliance, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wba#NASDAQ">WBA</a>) climbed 5.1% to close at $62.25 following a media report KKR is considering buying the company.</li>
<li>Internet Gold - Golden Lines Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/igld#NASDAQ">IGLD</a>) rose 5.1% to close at $12.86 after falling 12.57% on Friday.</li>
</ul>
<h3>
Losers</h3>
<ul>
<li>Lipocine Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lpcn#NASDAQ">LPCN</a>) shares dipped 70.7% to close at $0.80 on Monday after an adverse FDA verdict on its lead drug Tlando, previously known as LPCN 1021. Lipocine said Monday the FDA said &quot;nay&quot; for the third time for its Tlando, an oral testosterone replacement therapy for use in adult males for treating conditions associated with hypogonadism, which is a deficiency of endogenous testosterone. The complete response letter, or CRL, issued by the FDA signaling the application cannot be approved in the present form, pointed to one deficiency &mdash; the efficacy trial not meeting the three secondary endpoints for maximal testosterone concentration. The CRL, however, did not identify issues related to chemistry, manufacturing and controls.</li>
<li>ASLAN Pharmaceuticals Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asln#NASDAQ">ASLN</a>) dropped 68% to close at $0.6660 after the company reported that the TreeTopp global pivotal study of varlitinib in biliary tract cancer did not meet its co-primary endpoint.</li>
<li>NextCure, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxtc#NASDAQ">NXTC</a>) dropped 52.9% to close at $39.02 after the company announced a 44% patient discontinuation rate in its NC318 Phase 1/2 clinical trial.</li>
<li>RAPT Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rapt#NASDAQ">RAPT</a>) shares fell 30.3% to close at $19.60.</li>
<li>TimkenSteel Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tmst#NASDAQ">TMST</a>) dropped 25.7% to close at $5.47.</li>
<li>Foamix Pharmaceuticals Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fomx#NASDAQ">FOMX</a>) fell 19.8% to close at $3.48. Foamix Pharmaceuticals and Menlo Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnlo#NASDAQ">MNLO</a>) reported a merger agreement to create a combined biopharmaceutical company. Foamix Pharmaceuticals also reported worse-than-expected Q3 EPS results.</li>
<li>36KR HOLDINGS INC. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/krkr#NASDAQ">KRKR</a>) fell 17.8% to close at $10.74.</li>
<li>Neptune Wellness Solutions Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nept#NASDAQ">NEPT</a>) dropped 16.7% to close at $2.95 after the company reported second-quarter revenue of CA$6.51 million ($4.9 million)on Monday and announced a partnership with International Flavors &amp; Fragrances Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iff#NYSE">IFF</a>).</li>
<li>Assembly Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asmb#NASDAQ">ASMB</a>) shares declined 15.2% to close at $14.48.</li>
<li>Applied DNA Sciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apdn#NASDAQ">APDN</a>) dipped 15.2% to close at $4.40.</li>
<li>FibroGen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fgen#NASDAQ">FGEN</a>) tumbled 14.9% to close at $35.40. FibroGen reported worse-than-expected Q3 EPS results after the closing bell.</li>
<li>SunCoke Energy, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sxc#NYSE">SXC</a>) fell 14.2% to close at $5.15 on continued momentum after the company filed for a mixed shelf offering for up to $750 million.</li>
<li>Paringa Resources Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pnrl#NASDAQ">PNRL</a>) fell 14% to close at $ 2.15.</li>
<li>Adient plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/adnt#NYSE">ADNT</a>) dipped 13.2% to close at $21.24. The stock rallied approximately 8.5% on Q3 earnings and is now trading below its price level before earnings were released.</li>
<li>Extraction Oil &amp; Gas, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xog#NASDAQ">XOG</a>) tumbled 12.6% to close at $1.87 as a potential sell-off after the stock increased roughly 38% following the company reported better-than-expected Q3 EPS results last Thursday.</li>
<li>Airgain, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/airg#NASDAQ">AIRG</a>) dropped 12.1% to close at $10.02.</li>
<li>Ocular Therapeutix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocul#NASDAQ">OCUL</a>) fell 11.8% to close at $2.93 after the company reported strategic update and operational restructuring.</li>
<li>InnerWorkings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inwk#NASDAQ">INWK</a>) dipped 10.6% to close at $4.45.</li>
<li>Summit Midstream Partners, LP (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/smlp#NYSE">SMLP</a>) dropped 10.4% to close at $3.96.</li>
<li>Pacific Drilling S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pacd#NYSE">PACD</a>) dropped 10.3% to close at $3.14.</li>
<li>Synthesis Energy Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ses#NASDAQ">SES</a>) shares declined 10.2% to close at $7.99.</li>
<li>Akebia Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/akba#NASDAQ">AKBA</a>) dropped 9.9% to close at $3.66.</li>
<li>Evolent Health, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/evh#NYSE">EVH</a>) fell 8.4% to close at $9.27 after climbing 8.47% on Friday.</li>
<li>Uxin Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/uxin#NASDAQ">UXIN</a>) fell 7.9% to close at $3.15.</li>
<li>MyoKardia, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/myok#NASDAQ">MYOK</a>) fell 7.6% to close at $55.45.</li>
<li>NIO Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nio#NYSE">NIO</a>) dropped 6.1% to close at $1.86 after the company cut its electric car subsidies. The Chinese car sales have also declined for 16 consecutive months in October.</li>
<li>CytomX Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ctmx#NASDAQ">CTMX</a>) dropped 6.1% to close at $5.59. Wedbush downgraded CytomX Therapeutics from Outperform to Neutral and lowered the price target from $25 to $8.</li>
<li>Tonix Pharmaceuticals Holding Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tnxp#NASDAQ">TNXP</a>) shares dropped 6% to close at $2.54 following weak Q3 earnings.</li>
<li>Scientific Games Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sgms#NASDAQ">SGMS</a>) dipped 5.5% to close at $29.83 after Susquehanna downgraded the stock from Positive to Neutral.</li>
</ul>

<h3>Gainers</h3>
<ul>
<li>Taronis Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trnx#NASDAQ">TRNX</a>) shares gained 37.5% to $2.42.</li>
<li>Carbonite, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/carb#NASDAQ">CARB</a>) shares climbed 24.4% to $22.88 after the company announced it would be acquired by OpenText for $23 per share in cash.</li>
<li>TransEnterix, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/trxc#NYSE">TRXC</a>) shares gained 17.8% to $0.2670 after the company announced that Anthony Fernando was appointed as the new President and CEO.</li>
<li>Qurate Retail, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qrtea#NASDAQ">QRTEA</a>) gained 13.4% to $10.66 after the company reported better-than-expected Q3 EPS results.</li>
<li>Internet Gold - Golden Lines Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/igld#NASDAQ">IGLD</a>) rose 13.2% to $13.85 after falling 12.57% on Friday.</li>
<li>Aquestive Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aqst#NASDAQ">AQST</a>) shares jumped 12.8% to $6.09.</li>
<li>Jounce Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jnce#NASDAQ">JNCE</a>) shares gained 12.6% to $4.57.</li>
<li>XPEL, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xpel#NASDAQ">XPEL</a>) rose 12.5% to $12.16 after reporting strong Q3 results.</li>
<li>Entercom Communications Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/etm#NYSE">ETM</a>) gained 11.7% to $4.8250 on continued momentum after the company reported better-than-expected Q3 EPS and sales results.</li>
<li>Gravity Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grvy#NASDAQ">GRVY</a>) climbed 10.7% to $43.18.</li>
<li>Genie Energy Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gne#NYSE">GNE</a>) gained 9.7% to $7.90.</li>
<li>InMode Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inmd#NASDAQ">INMD</a>) shares climbed 9.3% to $44.18 on continued upward momentum. The stock has increased roughly 210% since its IPO in August 7.</li>
<li>Constellation Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnst#NASDAQ">CNST</a>) gained 8.8% to $33.64.</li>
<li>SunPower Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spwr#NASDAQ">SPWR</a>) shares rose 8.7% to $9.10 after the company announced plans to split into two independent publicly-traded companies.</li>
<li>Calumet Specialty Products Partners, L.P. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clmt#NASDAQ">CLMT</a>) jumped 8.5% to $3.69 after the company reported strategic divestiture of San Antonio Refinery, related assets to Starlight for $63 million in cash.</li>
<li>GTT Communications, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gtt#NYSE">GTT</a>) jumped 8.5% to $8.85.</li>
<li>CENTOGENE B.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cntg#NASDAQ">CNTG</a>) shares gained 7.8% to $14.00.</li>
<li>Medifast, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/med#NYSE">MED</a>) shares gained 7.2% to $79.72.</li>
<li>Walgreens Boots Alliance, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wba#NASDAQ">WBA</a>) climbed 6.3% to $62.97 following a media report KKR is considering buying the company.</li>
</ul>

<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>
<h3>Losers</h3>
<ul>
<li>Lipocine Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lpcn#NASDAQ">LPCN</a>) shares tumbled 69.2% to $0.84 after an adverse FDA verdict on its lead drug Tlando, previously known as LPCN 1021. Lipocine said Monday the FDA said &quot;nay&quot; for the third time for its Tlando, an oral testosterone replacement therapy for use in adult males for treating conditions associated with hypogonadism, which is a deficiency of endogenous testosterone. The complete response letter, or CRL, issued by the FDA signaling the application cannot be approved in the present form, pointed to one deficiency &mdash; the efficacy trial not meeting the three secondary endpoints for maximal testosterone concentration. The CRL, however, did not identify issues related to chemistry, manufacturing and controls.</li>
<li>ASLAN Pharmaceuticals Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asln#NASDAQ">ASLN</a>) fell 56.1% to $0.9139 after the company reported that the TreeTopp global pivotal study of varlitinib in biliary tract cancer did not meet its co-primary endpoint.</li>
<li>NextCure, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxtc#NASDAQ">NXTC</a>) dropped 51.8% to $39.92 after the company announced a 44% patient discontinuation rate in its NC318 Phase 1/2 clinical trial.</li>
<li>Foamix Pharmaceuticals Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fomx#NASDAQ">FOMX</a>) fell 26.7% to $3.18. Foamix Pharmaceuticals and Menlo Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnlo#NASDAQ">MNLO</a>) reported a merger agreement to create a combined biopharmaceutical company. Foamix Pharmaceuticals also reported worse-than-expected Q3 EPS results.</li>
<li>TimkenSteel Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tmst#NYSE">TMST</a>) dropped 23.1% to $5.66.</li>
<li>RAPT Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rapt#NASDAQ">RAPT</a>) shares fell 23.1% to $21.61.</li>
<li>Ocular Therapeutix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocul#NASDAQ">OCUL</a>) fell 15.8% to $2.7950 after the company reported strategic update and operational restructuring.</li>
<li>Tonix Pharmaceuticals Holding Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tnxp#NASDAQ">TNXP</a>) shares dropped 13.7% to $2.33 following weak Q3 earnings.</li>
<li>SELLAS Life Sciences Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sls#NASDAQ">SLS</a>) dipped 13.4% to $4.9779.</li>
<li>36KR HOLDINGS INC. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/krkr#NASDAQ">KRKR</a>) fell 12.7% to $11.40.</li>
<li>Extraction Oil &amp; Gas, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xog#NASDAQ">XOG</a>) tumbled 10.8% to $1.91 as a potential sell-off after the stock increased roughly 38% following the company reported better-than-expected Q3 EPS results last Thursday.</li>
<li>InnerWorkings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inwk#NASDAQ">INWK</a>) dipped 10.8% to $4.44.</li>
<li>MyoKardia, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/myok#NASDAQ">MYOK</a>) fell 10.8% to $53.53.</li>
<li>Vince Holding Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vnce#NYSE">VNCE</a>) dropped 10% to $19.58.</li>
<li>CytomX Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ctmx#NASDAQ">CTMX</a>) dropped 8.7% to $5.43. Wedbush downgraded CytomX Therapeutics from Outperform to Neutral and lowered the price target from $25 to $8.</li>
<li>Uxin Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/uxin#NASDAQ">UXIN</a>) fell 8.6% to $3.1250.</li>
<li>Scientific Games Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sgms#NASDAQ">SGMS</a>) dipped 8% to $29.05 after Susquehanna downgraded the stock from Positive to Neutral.</li>
<li>Evolent Health, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/evh#NYSE">EVH</a>) fell 8% to $9.32 after climbing 8.47% on Friday.</li>
<li>NIO Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nio#NYSE">NIO</a>) dropped 6.1% to $1.8597 after the company cut its electric car subsidies. The Chinese car sales have also declined for 16 consecutive months in October.</li>
</ul>

38 Stocks Moving In Monday's Mid-Day Session

<h3>Gainers</h3>
<ul>
<li>Nektar Therapeutics (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nktr#NASDAQ">NKTR</a>) shares rose 8.5% to $21.75 in pre-market trading. Nektar Therapeutics presented data from first-in-human Phase 1a study on Novel T regulatory cell stimulator, NKTR-358 at the ACR 2019.</li>
<li>Can-Fite BioPharma Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/canf#NYSE">CANF</a>) rose 8% to $2.57 in pre-market trading after the company was granted US Patent for piclidenoson in the treatment of osteoarthritis.</li>
<li>Medical Properties Trust, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mpw#NYSE">MPW</a>) rose 8% to $21.54 in pre-market trading.</li>
<li>Pier 1 Imports, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pir#NYSE">PIR</a>) rose 6.4% to $7.16 in pre-market trading after dropping 7.81% on Friday.</li>
<li>Amicus Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fold#NASDAQ">FOLD</a>) shares rose 6.2% to $9.49 in pre-market trading as the company reported upbeat earnings for its third quarter and raised the lower end of its Galafold revenue guidance.</li>
<li>SunPower Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spwr#NASDAQ">SPWR</a>) shares rose 5.6% to $8.84 in pre-market trading after the company announced plans to split into two independent publicly-traded companies.</li>
<li>Evolent Health, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/evh#NYSE">EVH</a>) rose 5.6% to $10.69 in pre-market trading after climbing 8.47% on Friday.</li>
<li>MyoKardia, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/myok#NASDAQ">MYOK</a>) rose 4.7% to $62.84 in pre-market trading.</li>
<li>Internet Gold - Golden Lines Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/igld#NASDAQ">IGLD</a>) rose 4% to $12.74 in pre-market trading after falling 12.57% on Friday.</li>
<li>Digital Turbine, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apps#NASDAQ">APPS</a>) rose 4% to $7.35 in pre-market trading.</li>
<li>Teva Pharmaceutical Industries Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/teva#NYSE">TEVA</a>) shares rose 3.8% to $9.65 in pre-market trading after gaining 9.80% on Friday.</li>
<li>PTC Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ptct#NASDAQ">PTCT</a>) rose 3.6% to $42.66 in pre-market trading. PTC Therapeutics said Risdiplam Pivotal SUNFISH study demonstrated statistically significant improvement for patients with Type 2/3 spinal muscular atrophy.</li>
<li>Inovalon Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inov#NASDAQ">INOV</a>) shares rose 3.2% to $17.20 in pre-market trading.</li>
</ul>
Find out what&#39;s going on in today&#39;s market and bring any questions you have to <a href="http://premarket.benzinga.com/pre-market-show/">Benzinga&#39;s PreMarket Prep</a>.
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>
<h3>Losers</h3>
<ul>
<li>NextCure, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxtc#NASDAQ">NXTC</a>) shares fell 55.4% to $37.00 in pre-market trading after the company announced updated clinical data from NC318 Phase 1/2 clinical trial presented at the SITC 2019.</li>
<li>Foamix Pharmaceuticals Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fomx#NASDAQ">FOMX</a>) fell 10.1% to $3.90 in pre-market trading. Foamix Pharmaceuticals and Menlo Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnlo#NASDAQ">MNLO</a>) reported a merger agreement to create a combined biopharmaceutical company.</li>
<li>Tupperware Brands Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tup#NYSE">TUP</a>) fell 6.3% to $8.75 after the company reported plans to suspend quarterly dividend.</li>
<li>Lumentum Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lite#NASDAQ">LITE</a>) fell 3.8% to $64.00 in pre-market trading.</li>
<li>United States Steel Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/x#NYSE">X</a>) fell 3.4% to $13.11 in pre-market trading.</li>
<li>Constellation Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnst#NASDAQ">CNST</a>) fell 3.4% to $29.87.</li>
<li>Rio Tinto Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rio#NYSE">RIO</a>) fell 3.3% to $52.35 in the pre-market trading session.</li>
</ul>

APPS

CANF

FOLD

INOV

LITE

NKTR

PTCT

TEVA

20 Stocks Moving in Monday's Pre-Market Session

Internet Gold - Golden Lines Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/igld#NASDAQ">IGLD</a>) today announced, further to the Company's report dated October 27, 2019 regarding B Communications Ltd.'s ("BComm") announcement of an updated anticipated schedule for closing of the Searchlight Transaction, that  on November 1, 2019 BComm announced an additional update to the anticipated schedule for closing of the Searchlight Transaction. According to BComm's announcement, the updated expected date for the closing of the Searchlight Transaction is November 21, 2019.
There is no guarantee that all conditions to the closing of the Searchlight Transaction will be satisfied, including, among others, the issuance of a control permit to the Purchasers by the Israel Ministry of  Communications. Accordingly, there is no guarantee that the Searchlight Transaction will be completed, and if completed, the timing of closing of the transaction.
As previously announced, if the Searchlight Transaction is completed, the Company will not be able to fully pay its debts, and the Company intends to initiate a creditors' arrangement which would be submitted to the applicable Israeli court. The Company anticipates that pursuant to such arrangement the existing shares of the Company will be nullified and that the creditors of the Company will receive, inter alia, 100% of the shares of the Company.

Internet Gold Announces Update to Anticipated Schedule for Closing of the Searchlight Transaction

Internet Gold Reports Submitted Appeal Of Nasdaq Listing Qualifications Notice On Oct. 29, 2019

﻿Internet Gold - Golden Lines Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/igld#NASDAQ">IGLD</a>) today announced that on October 22, 2019 it received a Notice of Delisting letter from the Listing Qualifications Department of Nasdaq.
As previously disclosed, on August 19, 2019, the Company was advised that it no longer complied with the continued listing standard set forth in Listing Rule 5450(b)(1)(B) (i.e., the minimum 750,000 publicly held shares' requirement). The Company submitted a plan to regain compliance on October 2, 2019, but Nasdaq Staff determined to deny the Company's request for an extension. Additionally, on September 26, 2019, as previously announced, the Nasdaq Staff notified the Company that it no longer complied with the minimum $10 million stockholders' equity requirement under Listing Rule 5450(b)(1)(A). The Company was granted until November 11, 2019 to submit its plan to regain compliance. However, pursuant to Listing Rule 5810(c)(2), Nasdaq Staff did not accept the Company's plan, and as a result, the failure to comply with the minimum $10 million stockholders' equity requirement was found to be an additional basis for delisting.
Accordingly, the Company was notified that its ordinary shares will be delisted from The Nasdaq Global Select Market unless the Company requests an appeal. The Company may prior to October 29, 2019 request either an oral hearing or a hearing based solely on written submissions. If it does not, the Company's ordinary shares will be suspended from trading on the Nasdaq Global Select Market at the opening of business on October 31, 2019 and a Form 25-NSE will be filed with the Securities and Exchange Commission (the "SEC"), which will remove the Company's securities from listing and registration on The Nasdaq Stock Market. The Company's shares will continue to be listed on the Tel-Aviv Stock Exchange.

Internet Gold Receives NASDAQ Notice of Delisting

Internet Gold - Golden Lines Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/igld#NASDAQ">IGLD</a>) today announced, further to the Company's report dated October 6, 2019, that B Communications Ltd. ("BComm") announced an updated anticipated schedule for closing of the Searchlight Transaction.  According to BComm's announcement, the updated expected date for the closing of the Searchlight Transaction is November 7, 2019.
There is no guarantee that all conditions to the closing of the Searchlight Transaction will be satisfied, including, among others, the issuance of a control permit to the Purchasers by the Israel Ministry of Communications. Accordingly, there is no guarantee that the Searchlight Transaction will be completed, and if completed, the timing of closing of the transaction.

BCOM

Internet Gold Announces November 7, 2019 as Anticipated Date for Closing of the Searchlight

<h3>Gainers</h3>
<ul>
<li>McDermott International, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mdr#NYSE">MDR</a>) rose 82.2% to $2.86 in pre-market trading after the company announced it will explore strategic alternatives for Lummus Technology. The company recently received unsolicited offers to acquire Lummus with a valuation of over $2.5 billion.</li>
<li>California Resources Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/crc#NYSE">CRC</a>) shares rose 17.9% to $11.67 in pre-market trading after falling 29.46% on Thursday.</li>
<li>Scholastic Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/schl#NASDAQ">SCHL</a>) rose 11% to $42.00 in pre-market trading after the company reported better-than-expected results for its first quarter.</li>
<li>HDFC Bank Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hdb#NYSE">HDB</a>) rose 8.1% to $110.84 in pre-market trading following a 5.32% surge in India&rsquo;s BSE Sensex.</li>
<li>Taronis Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trnx#NASDAQ">TRNX</a>) rose 8% to $2.45 in pre-market trading after climbing 14.07% on Thursday.</li>
<li>ICICI Bank Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ibn#NYSE">IBN</a>) rose 7.5% to $11.58 in pre-market trading following a 5.32% surge in India&rsquo;s BSE Sensex.</li>
<li>Tata Motors Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ttm#NYSE">TTM</a>) rose 6.8% to $9.38 in pre-market trading.</li>
<li>Precipio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prpo#NASDAQ">PRPO</a>) rose 6.3% to $2.55 in pre-market trading.</li>
<li>Steelcase Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/scs#NYSE">SCS</a>) rose 5.9% to $17.72 in pre-market trading after reporting better-than-expected Q2 results.</li>
<li>Vedanta Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vedl#NYSE">VEDL</a>) rose 5.5% to $8.70 in pre-market trading.</li>
<li>StoneCo Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stne#NASDAQ">STNE</a>) rose 4.9% to $39.10 in pre-market trading.</li>
<li>Kadmon Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kdmn#NASDAQ">KDMN</a>) rose 4.1% to $2.81 in pre-market trading.</li>
<li>Axonics Modulation Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/axnx#NASDAQ">AXNX</a>) shares rose 3.6% to $30.86 in pre-market trading after falling 5.16% on Thursday.</li>
<li>Lloyds Banking Group plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lyg#NYSE">LYG</a>) shares rose 3.4% to $2.75 in pre-market trading.</li>
<li>iQIYI, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iq#NASDAQ">IQ</a>) rose 3.2% to $19.60 in pre-market trading.</li>
<li>Hertz Global Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/htz#NYSE">HTZ</a>) rose 3% to $13.89 in pre-market trading.</li>
</ul>
Find out what&#39;s going on in today&#39;s market and bring any questions you have to <a href="http://premarket.benzinga.com/pre-market-show/">Benzinga&#39;s PreMarket Prep</a>.
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>
<h3>Losers</h3>
<ul>
<li>InspireMD Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nspr#NYSE">NSPR</a>) shares fell 40.8% to $1.54 in pre-market trading. InspireMD priced its 2.77 million unit underwritten public offering at $1.80 per unit.</li>
<li>HTG Molecular Diagnostics Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/htgm#NASDAQ">HTGM</a>) shares fell 15.1% to $0.68 in pre-market trading after the company reported a common stock offering.</li>
<li>Yuma Energy, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/yuma#NYSE">YUMA</a>) fell 7.6% to $4.60 in the pre-market trading session after dropping 3.11% on Thursday.</li>
<li>Internet Gold - Golden Lines Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/igld#NASDAQ">IGLD</a>) fell 7.1% to $22.00 in pre-market trading after declining 5.86% on Thursday.</li>
<li>Seadrill Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sdrl#NYSE">SDRL</a>) shares fell 6.9% to $2.42 in pre-market trading after dropping 10.65% on Thursday.</li>
<li>HyreCar Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hyre#NASDAQ">HYRE</a>) fell 6.3% to $2.39 in pre-market trading.</li>
<li>PG&amp;E Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pcg#NYSE">PCG</a>) shares fell 5% to $11.60 in pre-market trading.</li>
<li>Roku, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/roku#NASDAQ">ROKU</a>) fell 4.6% to $127.55 in pre-market trading after Pivotal Research initiated coverage on the stock with a Sell rating and a $60 price target.</li>
<li>Celldex Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cldx#NASDAQ">CLDX</a>) shares fell 3.6% to $2.42 in pre-market trading.</li>
<li>Xilinx, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xlnx#NASDAQ">XLNX</a>) fell 3.6% to $99.90 in the pre-market trading session after the company disclosed that the CFO Lorenzo Flores is stepping down. Bank of America downgraded the company&#39;s stock from Buy to Neutral.</li>
<li>Wheaton Precious Metals Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wpm#NYSE">WPM</a>) shares fell 3% to $26.51 in pre-market trading.</li>
</ul>

AXNX

CLDX

HTGM

HYRE

KDMN

NSPR

PRPO

ROKU

SCHL

SDRL

STNE

VEDL

XLNX

YUMA

26 Stocks Moving in Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Zosano Pharma Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zsan#NASDAQ">ZSAN</a>) shares rose 14.7% to $2.65 in pre-market trading after falling 7.97% on Wednesday.</li>
<li>Internet Gold - Golden Lines Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/igld#NASDAQ">IGLD</a>) rose 11.7% to $25.70 in pre-market trading after dropping 8.04% on Wednesday.</li>
<li>GSX Techedu Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gsx#NYSE">GSX</a>) shares rose 11.6% to $17.84 in pre-market trading after strong gains in revenue.</li>
<li>Nordstrom, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jwn#NYSE">JWN</a>) shares rose 9.3% to $29.01 in pre-market trading after the company reported better-than-expected Q2 EPS results.</li>
<li>Keysight Technologies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/keys#NYSE">KEYS</a>) rose 9% to $97.11 in pre-market trading after the company reported better-than-expected Q3 results. The company also issued Q4 guidance above analyst estimates.</li>
<li>GameStop Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gme#NYSE">GME</a>) rose 8.3% to $3.85 in the pre-market trading session.</li>
<li>Jumia Technologies AG (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jmia#NYSE">JMIA</a>) rose 7.6% to $13.20 in pre-market trading. RBC Capital upgraded Jumia Technologies from Sector Perform to Outperform and lowered the price target from $40 to $30.</li>
<li>BJ&#39;s Wholesale Club Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bj#NYSE">BJ</a>) rose 7.5% to $24.25 in pre-market trading after reporting upbeat Q2 earnings.</li>
<li>ZAGG Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zagg#NASDAQ">ZAGG</a>) rose 7.1% to $6.78 in pre-market trading after the NY Post, citing sources, reported there is a bidding war for the company.</li>
<li>Livongo Health, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lvgo#NASDAQ">LVGO</a>) shares rose 5.9% to $37.00 in pre-market trading.</li>
<li>Borr Drilling Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/borr#NYSE">BORR</a>) rose 5.8% to $5.67 in pre-market trading.</li>
<li>Mustang Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mbio#NASDAQ">MBIO</a>) rose 5.2% to $4.89 in pre-market trading after climbing 14.81% on Wednesday.</li>
<li>Tailored Brands, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tlrd#NYSE">TLRD</a>) rose 4.1% to $4.85 in pre-market trading after gaining 7.37% on Wednesday.</li>
<li>InspireMD, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nspr#NYSE">NSPR</a>) rose 4% to $2.65 in pre-market trading</li>
</ul>

Find out what&#39;s going on in today&#39;s market and bring any questions you have to <a href="http://premarket.benzinga.com/pre-market-show/">Benzinga&#39;s PreMarket Prep</a>.
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>
<h3>
Losers</h3>
<ul>
<li>Avinger, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avgr#NASDAQ">AVGR</a>) fell 31.1% to $1.15 in the pre-market trading session. Avinger priced 3,813,559 share underwritten public offering of common stock at $1.18 per share.</li>
<li>Retrophin, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rtrx#NASDAQ">RTRX</a>) fell 29.5% to $12.27 in pre-market trading after the company disclosed that its Phase 3 FORT study of fosmetpantotnate in patients with PKAN did not meet its primary or secondary endpoints.</li>
<li>Sociedad Qu&iacute;mica y Minera de Chile S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sqm#NYSE">SQM</a>) fell 8.5% to $23.24 in pre-market trading after the company reported results for its second quarter.</li>
<li>Yunji Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/yj#NASDAQ">YJ</a>) fell 8.3% to $8.90 in pre-market trading after reporting Q2 results.</li>
<li>Tata Motors Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ttm#NYSE">TTM</a>) fell 6.1% to $7.37 in pre-market trading after dropping 7.32% on Wednesday.</li>
<li>Huazhu Group Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/htht#NASDAQ">HTHT</a>) fell 5% to $30.09 in pre-market trading after the company reported better-than-expected Q2 sales results.</li>
<li>Allakos Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/allk#NASDAQ">ALLK</a>) shares fell 4.7% to $85.50 in pre-market trading.</li>
<li>FTI Consulting, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fcn#NYSE">FCN</a>) shares fell 3.8% to $103.51 in pre-market trading.</li>
<li>Splunk Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/splk#NASDAQ">SPLK</a>) fell 3.7% to $123.70 in pre-market trading. Splunk reported better-than-expected results for its second quarter and issued strong third-quarter sales guidance. The company also announced the acquisition of the SaaS company SignalFix for $1.05 billion.</li>
<li>58.com Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wuba#NYSE">WUBA</a>) shares fell 3.4% to $54.10 in pre-market trading following Q2 results.</li>
<li>SolarEdge Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sedg#NASDAQ">SEDG</a>) shares fell 3% to $85.30 in pre-market trading after announcing leave of absence of CEO and Founder, Guy Sella. UBS downgraded SolarEdge Technologies from Buy to Neutral and raised the price target from $73 to $90.</li>
<li>Coeur Mining, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cde#NYSE">CDE</a>) fell 2.5% to $4.80 in the pre-market trading session.</li>
</ul>

ALLK

AVGR

BORR

HTHT

JMIA

KEYS

LVGO

MBIO

RTRX

SEDG

SPLK

TLRD

WUBA

ZAGG

ZSAN

26 Stocks Moving in Thursday's Pre-Market Session

Internet Gold Receives Nasdaq Non-Compliance Notice;  Co. Has A 45 Days Period, Until October 3, 2019, To Submit A Plan To Regain Compliance

<h3>Gainers</h3>
<ul>
<li>DPW Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dpw#NYSE">DPW</a>) shares rose 121.4% to $4.56 in pre-market trading after the company announced that its subsidiary, Digital Power Lending has completed its beta testing of <a href="http://www.MonthlyInterest.com" title="www.MonthlyInterest.com">www.MonthlyInterest.com</a>, an online fintech portal that facilitates investments that pay monthly interest.</li>
<li>DryShips Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/drys#NASDAQ">DRYS</a>) rose 34.7% to $5.16 in pre-market trading after the company announced it will be acquired by SPII Holdings for $5.25 per share in cash.</li>
<li>China Green Agriculture, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cga#NYSE">CGA</a>) shares rose 22.9% to $4.35 in pre-market trading.</li>
<li>Empire Resorts, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nyny#NASDAQ">NYNY</a>) rose 13.3% to $9.57 in pre-market trading after the company agreed to be acquired by Kien Huat Realty and Genting Malaysia Berhad for $9.74 per share in cash.</li>
<li>Aramark (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/armk#NYSE">ARMK</a>) rose 13.2% to $42.00 in the pre-market trading session after winning a contract to be a food and beverage provider for Harbor Yard Amphitheater.</li>
<li>Salarius Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/slrx#NASDAQ">SLRX</a>) rose 13.1% to $7.10 in pre-market trading after gaining 10.37% on Friday.</li>
<li>Check-Cap Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chek#NASDAQ">CHEK</a>) rose 12.2% to $2.1772 in pre-market trading after the company announced the completion of manufacturing line transfer implementation and qualification for the C-Scan System.</li>
<li>Tailored Brands, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tlrd#NYSE">TLRD</a>) rose 11.7% to $5.65 in pre-market trading after the company announced to sell its corporate apparel business for $62 million in cash. The company also raised Q2 EPS guidance above analyst estimates.</li>
<li>Omeros Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/omer#NASDAQ">OMER</a>) rose 10.2% to $21.62 in pre-market trading after gaining 5.60% on Friday.</li>
<li>TrovaGene, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trov#NASDAQ">TROV</a>) shares rose 9.6% to $2.29 in pre-market trading after climbing 28.22% on Friday.</li>
<li>Genfit SA (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gnft#NASDAQ">GNFT</a>) shares 8.6% to $17.14 in pre-market trading after surging 5.83% on Friday.</li>
<li>SAExploration Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/saex#NASDAQ">SAEX</a>) rose 7.7% to $2.39 in pre-market trading after falling 32.11% on Friday.</li>
<li>Solid Biosciences Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sldb#NASDAQ">SLDB</a>) shares rose 7.3% to $9.45 in pre-market trading after jumping 43.25% on Friday.</li>
<li>TEGNA Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tgna#NYSE">TGNA</a>) shares rose 7.3% to $16.10 in the pre-market trading session after gaining 10.21% on Friday.</li>
<li>SINA Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sina#NASDAQ">SINA</a>) rose 7.3% to $40.39 in pre-market trading after the company reported upbeat results for its second quarter.</li>
<li>Weibo Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wb#NASDAQ">WB</a>) rose 6.8% to $39.60 in pre-market trading after the company reported better-than-expected Q2 EPS and sales results.</li>
<li>Marker Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrkr#NASDAQ">MRKR</a>) rose 6.7% to $5.89 in pre-market trading after climbing 15.00% on Friday.</li>
<li>Sonos, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sono#NASDAQ">SONO</a>) rose 6.4% to $12.67 in pre-market trading after Raymond James upgraded the company&#39;s stock from Outperform to Strong Buy.</li>
<li>CNH Industrial N.V. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cnhi#NYSE">CNHI</a>) rose 3.8% to $9.14 in pre-market trading after Morgan Stanley upgraded its rating of the company&#39;s stock from Equal-Weight to Overweight.</li>
</ul>

Find out what&#39;s going on in today&#39;s market and bring any questions you have to <a href="http://premarket.benzinga.com/pre-market-show/">Benzinga&#39;s PreMarket Prep</a>. 
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>
<h3>
Losers</h3>
<ul>
<li>PG&amp;E Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pcg#NYSE">PCG</a>) shares fell 19.8% to $11.45 in pre-market trading potentially due to a judge lifting a freeze on lawsuits related to a 2017 fire.</li>
<li>AptarGroup, Inc. . (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/atr#NYSE">ATR</a>) shares fell 15% to $102.25 in pre-market trading.</li>
<li>Vanda Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vnda#NASDAQ">VNDA</a>) fell 12.8% to $13.25 in pre-market trading after receiving a Complete Response Letter from the FDA for HETLIOZ in the treatment of jet lag disorder. The FDA said Vanda&#39;s study is of unclear clinical significance.</li>
<li>Internet Gold - Golden Lines Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/igld#NASDAQ">IGLD</a>) shares fell 8.9% to $26.00 in pre-market trading after surging 10.15% on Friday.</li>
<li>AutoWeb, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/auto#NASDAQ">AUTO</a>) fell 5.4% to $2.20 in the pre-market trading session after dropping 4.32% on Friday.</li>
<li>Valeritas Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vlrx#NASDAQ">VLRX</a>) shares fell 4.5% to $2.35 in pre-market trading.</li>
<li>Constellium SE (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cstm#NYSE">CSTM</a>) fell 3.4% to $10.69 in pre-market trading after rising 4.34% on Friday.</li>
<li>Obalon Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/obln#NASDAQ">OBLN</a>) fell 3.3% to $2.34 in pre-market trading after declining 4.35% on Friday.</li>
</ul>

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

FT Vest Gold Strategy Target Income ETF

Overview

FT Vest Gold Strategy Target Income ETF (BATS:IGLD), Quote.Headers.trade-ideas